• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Authors » Haky Moon

Haky Moon

Articles

ARTICLES

Med-tech start ups in Asia are a different beast from the west

Nov. 10, 2016
By Haky Moon

In Asia, regulatory harmonization in med tech clashes with the reality on the ground level

Nov. 9, 2016
By Haky Moon
SINGAPORE – Harmonization of regulations throughout the Asia Pacific region has been an ongoing goal in the past 20 years, but regulators across the region are now coming to accept that this particular goal may never be achieved. Regulators and industry stakeholders meeting in Singapore starting Tuesday for the Asia Pacific Medtech Forum 2016 said complete regional regulatory harmonization would be nice but is unlikely. While there has been some progress, a "harmonized regulatory environment will be impossible," said John Lim, deputy director of medical services at the Ministry of Health of Singapore. "If you...
Read More

In Asia, regulatory harmonization in med tech clashes with the reality on the ground level

Nov. 9, 2016
By Haky Moon
SINGAPORE – Harmonization of regulations throughout the Asia Pacific region has been an ongoing goal in the past 20 years, but regulators across the region are now coming to accept that this particular goal may never be achieved.
Read More

Pfizer’s vaccine business makes a comeback in China with Prevenar

Nov. 9, 2016
By Haky Moon
HONG KONG – With the approval of blockbuster vaccine Prevenar 13, Pfizer Inc. is making a comeback into China’s vaccine market after being forced to shut down operations last year.
Read More

Thailand FDA updates med-tech regulations, looks to enhance its e-health services

Nov. 8, 2016
By Haky Moon

Pfizer's vaccine business makes a comeback in China with Prevenar

Nov. 8, 2016
By Haky Moon
HONG KONG – With the approval of blockbuster vaccine Prevenar 13, Pfizer Inc. is making a comeback into China's vaccine market after being forced to shut down operations last year.
Read More

Doctor2u app delivers prescription meds at home

Nov. 7, 2016
By Haky Moon

Korea issues its own 3-D med-tech printing guidance

Nov. 1, 2016
By Haky Moon

Boryung, Kiara Health to supply cancer drugs to African countries

Oct. 26, 2016
By Haky Moon
HONG KONG – While prominent household names like Hanmi Pharmaceutical Co. Ltd, Celltrion Inc. and Samsung Biologics Co. Ltd. seem to be hogging the global stage, inking large numbers of out-licensing deals worth billions, lesser-known South Korean drugmakers are also looking outward – just not in the same direction.
Read More

Boryung, Kiara Health to supply cancer drugs to African countries

Oct. 25, 2016
By Haky Moon
HONG KONG – While prominent household names like Hanmi Pharmaceutical Co. Ltd, Celltrion Inc. and Samsung Biologics Co. Ltd. seem to be hogging the global stage, inking large numbers of out-licensing deals worth billions, lesser-known South Korean drugmakers are also looking outward – just not in the same direction.
Read More
View All Articles by Haky Moon

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 8, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 8, 2025.
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 8, 2025
  • Kidney disease illustration

    Prokidney produces positive phase II CKD data, thunderous stock surge

    BioWorld
    A mixed bag of top-line phase II data prompted stellar stock results for Prokidney Corp. and its chronic kidney disease (CKD) and diabetes therapy, rilparencel....
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe